203 related articles for article (PubMed ID: 4124700)
1. Prostatic adenocarcinoma of ductal origin.
Dube VE; Farrow GM; Greene LF
Cancer; 1973 Aug; 32(2):402-9. PubMed ID: 4124700
[No Abstract] [Full Text] [Related]
2. Prostatic adenocarcinoma of ductal origin.
Greene LF; Farrow GM; Ravits JM; Tomera FM
J Urol; 1979 Mar; 121(3):303-5. PubMed ID: 219263
[TBL] [Abstract][Full Text] [Related]
3. Histopathological pattern in prostatic adenocarcinomas: is it a prognostic criterion?
Bircan K; Başar I; Ergen A; Tekgül S; Ozbay G; Ozen HA
Int Urol Nephrol; 1991; 23(1):57-64. PubMed ID: 1657811
[TBL] [Abstract][Full Text] [Related]
4. Cyproterone acetate in the treatment of advanced carcinoma of the prostate.
Smith RB; Walsh PC; Goodwin WE
J Urol; 1973 Jul; 110(1):106-8. PubMed ID: 4713345
[No Abstract] [Full Text] [Related]
5. Lung metastases in prostatic carcinoma. Clinical significance.
Varkarakis MJ; Winterberger AR; Gaeta J; Moore RH; Murphy GP
Urology; 1974 Apr; 3(4):447-52. PubMed ID: 4856662
[No Abstract] [Full Text] [Related]
6. [Importance of serum acid phosphatase for the prognosis of prostatic carcinoma].
Breitwieser P; Nöske HD
Z Urol Nephrol; 1971 Apr; 64(4):249-56. PubMed ID: 5094006
[No Abstract] [Full Text] [Related]
7. [Prognosis and treatment of prostatic carcinoma].
Klug W
Zentralbl Chir; 1968 Mar; 93(10):362-6. PubMed ID: 5674208
[No Abstract] [Full Text] [Related]
8. Definitive radiation therapy of carcinoma of the prostate. A report on 15 years of experience.
Ray GR; Cassady JR; Bagshaw MA
Radiology; 1973 Feb; 106(2):407-18. PubMed ID: 4630765
[No Abstract] [Full Text] [Related]
9. A case report of a high serum acid phosphatase level in metastatic prostatic adenocarcinoma.
Sullivan H; Murthy NR
J Urol; 1971 Sep; 106(3):404. PubMed ID: 5097194
[No Abstract] [Full Text] [Related]
10. Carcinoma of the prostate of ductal origin.
Lemberger RJ; Bishop MC; Bates CP; Blundell W; Ansell ID
Br J Urol; 1984 Dec; 56(6):706-9. PubMed ID: 6085481
[TBL] [Abstract][Full Text] [Related]
11. Forty year experience with carcinoma of the male breast.
Vanderbilt PC; Warren SE
Surg Gynecol Obstet; 1971 Oct; 133(4):629-33. PubMed ID: 4328853
[No Abstract] [Full Text] [Related]
12. [Rate of survival in prostatic cancer with bone metastasis].
Kuntz D; Ryckewaert A
Rev Fr Etud Clin Biol; 1969; 14(6):609-13. PubMed ID: 5824263
[No Abstract] [Full Text] [Related]
13. Flow cytometric analysis of comedocarcinoma of the prostate: an uncommon histopathological variant of prostatic adenocarcinoma.
Currin SM; Lee SE; Walther PJ
J Urol; 1988 Jul; 140(1):96-100. PubMed ID: 2837590
[TBL] [Abstract][Full Text] [Related]
14. Biologic and pathophysiologic prognosticating indices in prostatic cancer.
Madduri SD; Sporer A; Seebode JJ
Am Surg; 1978 May; 44(5):290-5. PubMed ID: 666117
[No Abstract] [Full Text] [Related]
15. Hypophysectomy as compared with adrenalectomy in the treatment of advanced carcinoma of the breast.
Fracchia AA; Farrow JH; Miller TR; Tollefsen RH; Greenberg EJ; Knapper WH
Surg Gynecol Obstet; 1971 Aug; 133(2):241-6. PubMed ID: 4105232
[No Abstract] [Full Text] [Related]
16. Current status of bilateral adrenalectomy or advanced prostatic carcinoma.
Bhanalaph T; Varkarakis MJ; Murphy GP
Ann Surg; 1974 Jan; 179(1):17-23. PubMed ID: 4817870
[No Abstract] [Full Text] [Related]
17. Cribriform and glomeruloid acinar adenocarcinoma of the prostate-an intratumoural intraductal carcinoma?
Tolkach Y; Kristiansen G
Histopathology; 2019 May; 74(6):804-808. PubMed ID: 31006895
[No Abstract] [Full Text] [Related]
18. [Diagnosis and therapy of prostatic carcinoma].
Vahlensieck W; Tümmers H; Tschischak D
Fortschr Med; 1974 Oct; 92(30):1195-8. PubMed ID: 4138473
[No Abstract] [Full Text] [Related]
19. Intraductal Carcinoma of the Prostate.
Humphrey PA
J Urol; 2015 Nov; 194(5):1434-5. PubMed ID: 26291925
[No Abstract] [Full Text] [Related]
20. Prostatic carcinoma.
Klein LA
N Engl J Med; 1979 Apr; 300(15):824-33. PubMed ID: 106277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
